Andira Pharmaceuticals Achieves Remarkable Breast Cancer Tumor Regression with Lead Oncology Candidate XOXO4
Opportunity to invest in Canadian health science firm pioneering innovative treatments for breast cancer is now open globally to eligible investors. SAN FRANCISCO, OCTOBER 2023 – US Capital Global Securities…
Comments Off on Andira Pharmaceuticals Achieves Remarkable Breast Cancer Tumor Regression with Lead Oncology Candidate XOXO4
October 25, 2023
